356 related articles for article (PubMed ID: 8892903)
1. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
[TBL] [Abstract][Full Text] [Related]
2. 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
Franken M; Annis B; Ali AN; Wang F
J Virol; 1995 Dec; 69(12):8011-9. PubMed ID: 7494314
[TBL] [Abstract][Full Text] [Related]
3. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
5. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
6. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Cyno-EBV LMP1 homologue and comparison with LMP1s of EBV and other EBV-like viruses.
Faucher S; Dimock K; Wright KE
Virus Res; 2002 Dec; 90(1-2):63-75. PubMed ID: 12457963
[TBL] [Abstract][Full Text] [Related]
9. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
10. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
Kaye KM; Devergne O; Harada JN; Izumi KM; Yalamanchili R; Kieff E; Mosialos G
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11085-90. PubMed ID: 8855313
[TBL] [Abstract][Full Text] [Related]
12. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
13. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
Wu S; Xie P; Welsh K; Li C; Ni CZ; Zhu X; Reed JC; Satterthwait AC; Bishop GA; Ely KR
J Biol Chem; 2005 Sep; 280(39):33620-6. PubMed ID: 16009714
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.
Mosialos G; Birkenbach M; Yalamanchili R; VanArsdale T; Ware C; Kieff E
Cell; 1995 Feb; 80(3):389-99. PubMed ID: 7859281
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
16. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
Mainou BA; Everly DN; Raab-Traub N
J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
[TBL] [Abstract][Full Text] [Related]
17. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
18. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
[TBL] [Abstract][Full Text] [Related]
19. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
20. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
